Beech Tree Labs and its predecessor, Milkhaus Laboratory, have conducted a number of controlled clinical trials that individually and collectively demonstrate the promise of the RMS approach to therapy. Disorders targeted in the successful trials include:
Benign Prostatic Hyperplasia
Chronic Fatigue Syndrome
Chronic Obstructive Pulmonary Disease
Cancer (FDA and USDA)
Validation of this approach is also found in the publication of peer-reviewed papers addressing the mechanism of action and clinical efficacy of Beech Tree’s therapeutic agents.